For free or for fee? Dilemma of small scientific journals.

Biomedical publishing is becoming increasingly dominated by multinational companies, advertising research articles at the international market, presenting them electronically through web-based services, and distributing them to readers-consumers. It seems that they will soon become the sole publishers for the majority of biomedical journals. In the past decade, however, we witnessed a quiet revolution in the whole structure of scientific communication, influenced by new technologies and initiatives such as Open Access, PubMedCentral, PLoS, and BioMedCentral. The Croatian Medical Journal (CMJ) has recently been approached by two major publishing companies and offered to become one of the journals in their group. The editorial decision was to join neither of the publishers. We felt that the decision had to be explained to our readers by defining CMJ's position in global scientific and medical journal publishing. Our experience may be similar to that of the many biomedical journals which find themselves in a dilemma whether to join major publishers or not.